- Home
- VTRS vs WYNN Comparison
VTRS vs WYNN Comparison
Compare VTRS & WYNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VTRS
- WYNN
- Stock Information
- Founded
- VTRS 1961
- WYNN 2002
- Country
- VTRS United States
- WYNN United States
- Employees
- VTRS N/A
- WYNN N/A
- Industry
- VTRS Medicinal Chemicals and Botanical Products
- WYNN Hotels/Resorts
- Sector
- VTRS Health Care
- WYNN Consumer Discretionary
- Exchange
- VTRS Nasdaq
- WYNN Nasdaq
- Market Cap
- VTRS 12.2B
- WYNN 12.2B
- IPO Year
- VTRS N/A
- WYNN 2002
- Fundamental
- Price
- VTRS $10.76
- WYNN $121.47
- Analyst Decision
- VTRS Hold
- WYNN Strong Buy
- Analyst Count
- VTRS 6
- WYNN 11
- Target Price
- VTRS $11.17
- WYNN $136.00
- AVG Volume (30 Days)
- VTRS 9.1M
- WYNN 1.6M
- Earning Date
- VTRS 11-06-2025
- WYNN 11-06-2025
- Dividend Yield
- VTRS 4.40%
- WYNN 0.82%
- EPS Growth
- VTRS N/A
- WYNN N/A
- EPS
- VTRS N/A
- WYNN 4.59
- Revenue
- VTRS $14,124,400,000.00
- WYNN $7,110,738,000.00
- Revenue This Year
- VTRS N/A
- WYNN $0.86
- Revenue Next Year
- VTRS $1.61
- WYNN $4.30
- P/E Ratio
- VTRS N/A
- WYNN $26.46
- Revenue Growth
- VTRS N/A
- WYNN N/A
- 52 Week Low
- VTRS $6.85
- WYNN $65.25
- 52 Week High
- VTRS $13.55
- WYNN $134.23
- Technical
- Relative Strength Index (RSI)
- VTRS 57.42
- WYNN 47.29
- Support Level
- VTRS $9.92
- WYNN $119.60
- Resistance Level
- VTRS $11.28
- WYNN $134.21
- Average True Range (ATR)
- VTRS 0.35
- WYNN 4.48
- MACD
- VTRS 0.04
- WYNN -0.02
- Stochastic Oscillator
- VTRS 61.43
- WYNN 20.96
About VTRS Viatris Inc.
Viatris was formed in November 2020 through the combination of Upjohn, a wholly owned subsidiary of Pfizer that specialized in off-patent drugs, and Mylan, a global pharmaceutical manufacturer that focused on generic and specialty drugs. By joining forces, Viatris became one of the largest generic drug manufacturers in the world, servicing over 165 countries. Generics (commoditized and complex) and biosimilars make up roughly 40% of Viatris' total sales. The remaining 60% of sales are derived from its portfolio of legacy products, which includes Lipitor, Norvasc, Lyrica, and Viagra. While it covers more than 10 major therapeutic areas, Viatris has identified dermatology, ophthalmology, and gastroenterology as its three key areas of focus for future innovations.
About WYNN Wynn Resorts Limited Common stock
Wynn Resorts operates luxury casinos and resorts. The company was founded in 2002 by Steve Wynn, the former CEO. The company operates four megaresorts: Wynn Macau and Encore in Macao and Wynn Las Vegas and Encore in Las Vegas. Cotai Palace opened in August 2016 in Macao, and Encore Boston Harbor in Massachusetts opened June 2019. We expect the company to continue to build nongaming attractions in Macao over the next few years. We model Wynn's managed integrated resort in the United Arab Emirates to open in 2027. The company also operates Wynn Interactive, a digital sports betting and iGaming platform. The company received 76% and 24% of its 2019 prepandemic EBITDA from Macao and the US, respectively. In 2024, both the US and Macao were each 50% of total EBITDA.